BIVRX vs. FSCEX
Compare and contrast key facts about Invenomic Fund (BIVRX) and Fidelity Advisor Small Cap Fund Class C (FSCEX).
BIVRX is managed by Invenomic. It was launched on Jun 18, 2017. FSCEX is managed by Fidelity. It was launched on Sep 9, 1998.
Performance
BIVRX vs. FSCEX - Performance Comparison
Loading graphics...
BIVRX vs. FSCEX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 5.94% | 4.39% | -9.03% | 16.47% | 49.61% | 44.06% | 11.12% | 11.36% | 3.41% | 8.73% |
FSCEX Fidelity Advisor Small Cap Fund Class C | 0.43% | 11.04% | -11.92% | 17.31% | -21.33% | 30.13% | 16.12% | 31.37% | -16.86% | 7.46% |
Returns By Period
In the year-to-date period, BIVRX achieves a 5.94% return, which is significantly higher than FSCEX's 0.43% return.
BIVRX
- 1D
- 3.43%
- 1M
- 2.62%
- YTD
- 5.94%
- 6M
- 11.17%
- 1Y
- 6.87%
- 3Y*
- 1.70%
- 5Y*
- 13.81%
- 10Y*
- —
FSCEX
- 1D
- -1.75%
- 1M
- -7.93%
- YTD
- 0.43%
- 6M
- 3.68%
- 1Y
- 21.77%
- 3Y*
- 3.18%
- 5Y*
- 0.65%
- 10Y*
- 6.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIVRX vs. FSCEX - Expense Ratio Comparison
BIVRX has a 2.48% expense ratio, which is higher than FSCEX's 2.04% expense ratio.
Return for Risk
BIVRX vs. FSCEX — Risk / Return Rank
BIVRX
FSCEX
BIVRX vs. FSCEX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and Fidelity Advisor Small Cap Fund Class C (FSCEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BIVRX | FSCEX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.32 | 0.99 | -0.67 |
Sortino ratioReturn per unit of downside risk | 0.65 | 1.51 | -0.86 |
Omega ratioGain probability vs. loss probability | 1.07 | 1.20 | -0.13 |
Calmar ratioReturn relative to maximum drawdown | 0.41 | 1.40 | -0.98 |
Martin ratioReturn relative to average drawdown | 0.93 | 5.96 | -5.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BIVRX | FSCEX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.32 | 0.99 | -0.67 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.82 | 0.03 | +0.79 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.29 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.91 | 0.37 | +0.53 |
Correlation
The correlation between BIVRX and FSCEX is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
BIVRX vs. FSCEX - Dividend Comparison
BIVRX's dividend yield for the trailing twelve months is around 1.82%, less than FSCEX's 3.56% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 1.82% | 1.93% | 3.55% | 20.26% | 28.43% | 3.00% | 3.11% | 3.21% | 4.82% | 1.21% | 0.00% | 0.00% |
FSCEX Fidelity Advisor Small Cap Fund Class C | 3.56% | 3.58% | 0.00% | 2.23% | 8.66% | 16.35% | 3.97% | 5.72% | 20.54% | 18.60% | 2.60% | 10.50% |
Drawdowns
BIVRX vs. FSCEX - Drawdown Comparison
The maximum BIVRX drawdown since its inception was -18.29%, smaller than the maximum FSCEX drawdown of -51.02%. Use the drawdown chart below to compare losses from any high point for BIVRX and FSCEX.
Loading graphics...
Drawdown Indicators
| BIVRX | FSCEX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -18.29% | -51.02% | +32.73% |
Max Drawdown (1Y)Largest decline over 1 year | -13.79% | -13.79% | 0.00% |
Max Drawdown (5Y)Largest decline over 5 years | -17.66% | -41.37% | +23.71% |
Max Drawdown (10Y)Largest decline over 10 years | — | -41.37% | — |
Current DrawdownCurrent decline from peak | -1.19% | -19.11% | +17.92% |
Average DrawdownAverage peak-to-trough decline | -5.91% | -12.73% | +6.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.14% | 3.23% | +2.91% |
Volatility
BIVRX vs. FSCEX - Volatility Comparison
Invenomic Fund (BIVRX) has a higher volatility of 7.61% compared to Fidelity Advisor Small Cap Fund Class C (FSCEX) at 6.46%. This indicates that BIVRX's price experiences larger fluctuations and is considered to be riskier than FSCEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BIVRX | FSCEX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.61% | 6.46% | +1.15% |
Volatility (6M)Calculated over the trailing 6-month period | 16.65% | 12.63% | +4.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.73% | 21.95% | -1.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.96% | 23.18% | -6.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.09% | 22.47% | -5.38% |